An Update on the Genetics of Diabetic Retinopathy

Many studies have found statistically significant associations between gene…

Read Article
  • AMD in 2017: A Review of Treatment Guidelines and the Role of Early Appropriate Therapy

    Read Article


Visit @RetinaToday on Twitter

Articles From This Issue


Medical Editors’ Page | Making Strides Against Diabetic Eye Disease

Raise your hand if you know someone with diabetes (patients don’t count). With more than 21.0 million Americans diagnosed with diabetes,1 chances are your hand is ra…

Retina News

LONGER-TERM DME OUTCOMES PREDICTED BY EARLY RESPONSE TO ANTI-VEGF THERAPY Eyes with diabetic macular edema (DME) that have an early response to anti-VEGF treatment, measure…

  • Diabetes Awareness Month
  • OCT-A Disease Education Resource Center
  • AMD Awareness Month
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • NEWS


    NightstaRx Commences First Phase 1/2 Gene Therapy Clinical Trial for Patients with X-Linked Retinitis Pigmentosa

    NightstaRx, a biopharmaceutical company specialising in developing gene therapies for inherited reti…

    Aerpio Pharmaceuticals Raises $40 Million

    Aerpio Pharmaceuticals, a biopharmaceutical company focused on advancing first-in-class treatments f…

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Karen Roman

    Janet Burk

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.